It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Intellectual disability (ID) and autism spectrum disorder (ASD) are the most common neurodevelopmental disorders and are characterized by substantial impairment in intellectual and adaptive functioning, with their genetic and molecular basis remaining largely unknown. Here, we identify biallelic variants in the gene encoding one of the Elongator complex subunits, ELP2, in patients with ID and ASD. Modelling the variants in mice recapitulates the patient features, with brain imaging and tractography analysis revealing microcephaly, loss of white matter tract integrity and an aberrant functional connectome. We show that the Elp2 mutations negatively impact the activity of the complex and its function in translation via tRNA modification. Further, we elucidate that the mutations perturb protein homeostasis leading to impaired neurogenesis, myelin loss and neurodegeneration. Collectively, our data demonstrate an unexpected role for tRNA modification in the pathogenesis of monogenic ID and ASD and define Elp2 as a key regulator of brain development.
Subunits of the Elongator complex have been implicated in several nervous system pathologies. Here, the authors identify ELP2 variants in six patients with neurodevelopmental anomalies and show in mouse models that these variants impact protein stability and the activity of the complex during brain development.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
















1 The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The University of Queensland, Institute for Molecular Bioscience, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
2 Jagiellonian University, Malopolska Centre of Biotechnology, Krakow, Poland (GRID:grid.5522.0) (ISNI:0000 0001 2162 9631)
3 The University of Queensland, Institute for Molecular Bioscience, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
4 Jagiellonian University, Malopolska Centre of Biotechnology, Krakow, Poland (GRID:grid.5522.0) (ISNI:0000 0001 2162 9631); Postgraduate School of Molecular Medicine, Warsaw, Poland (GRID:grid.5522.0)
5 The University of Queensland, Centre for Advanced Imaging, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
6 Walter and Eliza Hall Institute of Medical Research, Bioinformatics Division, Melbourne, Australia (GRID:grid.1042.7); The University of Melbourne, Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
7 The University of Queensland, School of Biomedical Sciences, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
8 The University of Queensland, Institute for Molecular Bioscience, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
9 Danish Epilepsy Centre, Department of Epilepsy Genetics and Personalized Medicine, Dianalund, Denmark (GRID:grid.452376.1)
10 Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark (GRID:grid.411905.8) (ISNI:0000 0004 0646 8202)
11 Division of Neurogenetics, Kennedy Krieger Institute, Department of Neurology and Developmental Medicine, Baltimore, USA (GRID:grid.240023.7) (ISNI:0000 0004 0427 667X); Johns Hopkins University School of Medicine, Department of Neurology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
12 Division of Neurogenetics, Kennedy Krieger Institute, Department of Neurology and Developmental Medicine, Baltimore, USA (GRID:grid.240023.7) (ISNI:0000 0004 0427 667X); Johns Hopkins University School of Medicine, Department of Neurology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
13 The University of Melbourne, Department of Paediatrics, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Murdoch Children’s Research Institute, Victorian Clinical Genetics Services, Melbourne, Australia (GRID:grid.1058.c) (ISNI:0000 0000 9442 535X); Australian Genomics Health Alliance, Parkville, Australia (GRID:grid.1058.c)
14 Murdoch Children’s Research Institute, Victorian Clinical Genetics Services, Melbourne, Australia (GRID:grid.1058.c) (ISNI:0000 0000 9442 535X); Australian Genomics Health Alliance, Parkville, Australia (GRID:grid.1058.c); The University of Melbourne, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
15 The University of Melbourne, Department of Paediatrics, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Royal Children’s Hospital, Department of Metabolic Medicine, Parkville, Australia (GRID:grid.416107.5) (ISNI:0000 0004 0614 0346)
16 Regional Hospital Viborg, Department of Paediatrics, Viborg, Denmark (GRID:grid.416107.5)
17 Pitié-Salpêtrière Hospital, AP-HP, Department of Genetics, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058)
18 The University of Colorado Anschutz, Children’s Hospital Colorado, Aurora, USA (GRID:grid.413957.d) (ISNI:0000 0001 0690 7621)
19 The University of Queensland, Queensland Brain Institute, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The Park Centre for Mental Health, Queensland Centre for Mental Health Research, Brisbane, Australia (GRID:grid.417162.7) (ISNI:0000 0004 0606 3563)
20 Queensland University of Technology, CSIRO-QUT Synthetic Biology Alliance, Centre for Tropical Crops and Bio-commodities, Brisbane, Australia (GRID:grid.1024.7) (ISNI:0000000089150953)
21 The University of Queensland, Institute for Molecular Bioscience, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The Ruprecht Karl University of Heidelberg, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
22 Walter and Eliza Hall Institute of Medical Research, Bioinformatics Division, Melbourne, Australia (GRID:grid.1042.7); The University of Melbourne, Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); The University of Melbourne, Department of Clinical Pathology, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
23 The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
24 Danish Epilepsy Centre, Department of Epilepsy Genetics and Personalized Medicine, Dianalund, Denmark (GRID:grid.452376.1); The University of Southern Denmark, Department for Regional Health Research, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)